Non-small cell lung cancer is the most common type of lung cancer. Surgery appears to be the most effective treatment in early stage although it has important impact on quality of life. Pulmonary rehabilitation (PR), both before and after surgery, could reduce symptoms and morbidity and improve exercise capacity, pulmonary function and quality of life. Aim. Assess the efficacy of a pre and post-operative PR programme (PUREAIR) for lung cancer patients on exercise capacity and quality of life.
PRELIMINARY DATA OF AN EARLY PULMONARY REHABILITATION PROGRAMME IN SURGICALLY TREATED LUNG CANCER PATIENTS / Mainini, C; Bardelli, R; Kopliku, B; Sobral Rebelo, Pf; Cantarelli, L; Tenconi, S; Rapicetta, C; Piro, R; Costi, S; Galeone, C; Ruggiero, P; Tedeschi, C; Fugazzaro, S. - (2017). (Intervento presentato al convegno 11th International Society of Physical and Rehabilitation Medicine (ISPRM) World Congress tenutosi a Buenos Aires nel april 30 - may 4, 2017).
PRELIMINARY DATA OF AN EARLY PULMONARY REHABILITATION PROGRAMME IN SURGICALLY TREATED LUNG CANCER PATIENTS
Piro R;Costi S;
2017
Abstract
Non-small cell lung cancer is the most common type of lung cancer. Surgery appears to be the most effective treatment in early stage although it has important impact on quality of life. Pulmonary rehabilitation (PR), both before and after surgery, could reduce symptoms and morbidity and improve exercise capacity, pulmonary function and quality of life. Aim. Assess the efficacy of a pre and post-operative PR programme (PUREAIR) for lung cancer patients on exercise capacity and quality of life.
| File | Dimensione | Formato | |
|---|---|---|---|
|
poster ISPRM.ppt
Open access
Tipologia:
Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione
507.5 kB
Formato
Microsoft Powerpoint
|
507.5 kB | Microsoft Powerpoint | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
